Bayer Intellectual Property Gmbh

Bayer Animal Health Gmbh

Bayer Pharma Aktiengesellschaft

Bayer Schering Pharma Ag

Adam Nitsche

Peter Kolkhof

Karl-Heinz Schlemmer

Rolf Grosser

Lars Bärfacker

Barbara Albrecht-Küpper

Klaus Münter

Elke Hartmann

Martina Klein

Andreas Knorr

Klemens Lustig

Carsten Schmeck

Heinrich Meier

Yolanda Cancho Grande

Ingo Flamme

Jens Schamberger

Santiago Figueroa Perez

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use

Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof

The present application relates to novel aryl-substituted 3-cyano-5-thiazolyl- and 3-cyano-5-thiadiazolyl-1,4-dihydropyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof

The present application relates to novel substituted 6-phenylnicotinic acid derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prophylaxis of cardiovascular disorders, in particular dyslipidaemias, arteriosclerosis and heart failure.

Substituted 6-phenylnicotinic acids and their use

Growing community of inventors

Pulheim, Germany

Adam Nitsche